Diabetic adults who have had a heart attack in the last 6 months are needed for a research study
15772
A randomized, double-blind, placebo controlled, parallel-group, multicenter study to evaluate cardiovascular outcomes during treatment with lixisenatide in type 2 diabetic patients after an Acute Coronary Syndrome
Internal Medicine
McCall Anthony,
UVa Endocrinology invites adults over 30 years old with Type 2 diabetes, who have had a heart attack in the last 6 months to be part of a research study. The purpose of the study is to see is to see if this experimental drug is effective at preventing cardiovascular events such as a heart attack in patients with type 2 diabetes. The study involves taking a daily injection experimental medicine, blood draws, EKGs as well as coming into clinic every 6 weeks for 45 minutes for a 2 year duration. ? Study-related exams, blood tests and experimental medication are provided free of charge. ? Compensation for study completion is $350. Contact Information: • Michele Rehan, MS • Division of Endocrinology • 434-243-5652 • mer5b@virginia.edu IRB-HSR # 15772 Principal Investigator: Anthony McCall, MD
Endocrinology
Adult
Diabetes Type 2
Heart Attack (Myocardial Infarction)
Endocrinology
Cardiology/Vascular
Ill
No Compensation
Michele Rehan
mer5b@virginia.edu
4342435652
